Hu, Jinxiu
Qiao, Jiao
Yu, Qun
Liu, Bing
Zhen, Junhui
Liu, Yue
Ma, Qiqi
Li, Yanmei
Wang, Qianhui
Wang, Cheng
Lv, Zhimei http://orcid.org/0000-0002-5704-2151
Funding for this research was provided by:
National Natural Science Foundation of China (81873615, 81770723, 81400732)
National Natural Science Foundation of China (81370834)
The Science and Technology Innovation Program of Clinical Medicine from the Jinan Science and Technology Bureau (201805054)
The Science and Technology Innovation Program of Clinical Medicine from the Jinan Science and Technology Bureau (201805001)
Academic promotion programme of Shandong First Medical University (2019QL022)
Taishan Scholars Program of Shandong Province (tsqn201812138)
Taishan Scholars Program of Shandong Province (ts201712090)
Article History
Received: 6 December 2020
Accepted: 23 January 2021
First Online: 15 February 2021
Ethics approval and consent to participate
: The human study was approved by the Clinical Research Ethics Committee of Shandong Provincial Hospital Affiliated to Shandong University (No: 2020–901), and the informed consent was signed by all participants in accordance with the Declaration of Helsinki. All animal experiments were approved by the Animal Care and Use Committee of Shandong University (No: 2019–001).
: All authors have read the manuscript and approved its submission to the Journal of Translational Medicine.
: The authors declare that they have no competing interests.